TipRanks
Go Ultimate55% OFF

Summer - New Portfolio

Tom Bar Hava

Tom Bar Hava

SummerIndividual Investor
Ranked #621,425 out of 882,537 TipRanks' Investors
Success Rateⓘ33%9 out of 27
profitable transactions
Average Returnⓘ-12.37%Average return
per transaction

Portfolio Gain

1-Month Return▼5.79%
6-Month Return-
12-Month Return-
YTD Return▼22.34%
Total Return▼22.34%

Best Trade

Opened atJun 22, 2026
Closed atAug 04, 2026
Gain▲36.12%

Bio

God is dead

Performance

-16.06%0.00%16.06%Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
TipRanks Average▼ 0.82%▲ 16.06%▲ 15.50%▼ 5.57%▼ 4.52%▲ 11.68%▲ 3.10%▼ 8.57%
S&P 500▼ 4.94%▲ 10.51%▲ 5.26%▼ 1.03%▲ 0.03%▲ 2.68%▼ 0.33%▼ 0.91%
Investor Portfolio---▼ 0.19%▼ 13.87%▲ 16.05%▼ 15.78%▼ 7.57%

Recent Activity

Company Name% of PortfolioReturnNo. of TransactionsLast Transaction▼Date
QLDProShares Ultra QQQ
—▼2.10%5CloseOct 31, 2026
ADIAnalog Devices
30.9%▲6.22%2BuyOct 23, 2026
TSMTSMC
—▼8.89%3CloseOct 16, 2026
TQQQProShares UltraPro QQQ
—▼7.97%2CloseOct 16, 2026
QSQuantumScape
—▼39.61%4CloseSep 29, 2026
PYPLPayPal Holdings
5.81%▲5.03%1OpenSep 28, 2026
CCJCameco
4.27%▼11.64%1OpenSep 28, 2026
SMMTSummit Therapeutics
3.71%▲2.69%1OpenSep 25, 2026
PRAXPraxis Precision Medicines
7.94%▼13.32%2BuySep 17, 2026
RNAAtrium Therapeutics, Inc.
9.19%▼34.62%3BuySep 08, 2026
XBISPDR S&P BIOTECH ETF
5.42%▼4.78%1OpenSep 04, 2026
CAPRCapricor Therapeutics
3.37%▼35.49%1OpenSep 02, 2026
VNDAVanda
3.58%▼31.46%1OpenSep 02, 2026
CRSPCrispr Therapeutics AG
—▲9.46%2CloseAug 21, 2026
PLTRPalantir Technologies
—▲28.86%4CloseAug 04, 2026
NRIXNurix Therapeutics
—▲27.88%4CloseJul 15, 2026
VERAVera Therapeutics
12.05%▼27.24%2BuyJul 15, 2026
UNCYUnicycive Therapeutics
6.55%▼40.30%2BuyJul 01, 2026